GetTopicDetailResponse(id=3cf81132e47d, topicName=圍手術期化療, introduction=圍手術期化療, content=胃癌 輔助化療 Ⅲ期試驗 圍手術期化療, image=null, comments=0, allHits=1043, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Apr 11 10:41:36 CST 2024, time=2024-04-11, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=476968, tagList=[TagDto(tagId=476968, tagName=圍手術期化療)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2253309, encodeId=51352253309df, content=<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> <a href='/topic/show?id=3cf81132e47d' target=_blank style='color:#2F92EE;'>#圍手術期化療#</a>, objectTitle=《柳葉刀-腫瘤學》：60%患者存活5年！沈琳/季加孚團隊研究為亞洲局晚期胃癌帶來新治療方案, objectType=article, longId=864343, objectId=a46d86434398, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240717/1721183712728_92910.jpg, objectUrl=/article/show_article.do?id=a46d86434398, replyNumber=0, likeNumber=42, createdTime=2025-02-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=a46d86434398, moduleTitle=《柳葉刀-腫瘤學》：60%患者存活5年！沈琳/季加孚團隊研究為亞洲局晚期胃癌帶來新治療方案, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a46d86434398)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197939, encodeId=d1c2219e93983, content=<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> <a href='/topic/show?id=6dfa936e3a5' target=_blank style='color:#2F92EE;'>#輔助化療#</a> <a href='/topic/show?id=769995e97d' target=_blank style='color:#2F92EE;'>#Ⅲ期試驗#</a> <a href='/topic/show?id=3cf81132e47d' target=_blank style='color:#2F92EE;'>#圍手術期化療#</a>, objectTitle=J HEMATOL ONCOL： 可切除胃癌患者圍術期與輔助化療的對比研究（RESONANCE）：一項隨機、開放標簽、III期臨床試驗, objectType=article, longId=821079, objectId=85c78210e956, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240410/1712755015759_6145188.png, objectUrl=/article/show_article.do?id=85c78210e956, replyNumber=0, likeNumber=120, createdTime=2024-04-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=85c78210e956, moduleTitle=J HEMATOL ONCOL： 可切除胃癌患者圍術期與輔助化療的對比研究（RESONANCE）：一項隨機、開放標簽、III期臨床試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=85c78210e956)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-04-11發(fā)表于上海
